We prospectively investigated the clinical parameters that influenced pain during prostate biopsies. From 12 hospitals 1781 patients were enrolled. The patients completed a visual analogue scale questionnaire for the pain during the procedure. Age, enema preparation, analgesia use and number of biopsy punctures influenced the level of pain during prostate biopsy in univariate linear regression analysis. However, multivariate analysis showed enema preparation, analgesia use and number of biopsy punctures were independent factors associated with the pain during the procedure. Our study confirmed enema preparation before biopsy and the number of biopsy punctures were associated with the pain during prostate biopsy.
Introduction
Prostate cancer is one of the most common cancers in Western countries and is now increasing worldwide. 1, 2 Although several diagnostic imaging methods for prostate cancer have been developed, diagnosis of prostate cancer is still dependent on a prostate biopsy. During the last decade the development and application of prostate biopsy techniques have continued to expand, while only a minor emphasis has focused on reducing pain during the procedure. 3 Transrectal ultrasonography (TRUS)-guided prostate biopsies are widely considered procedures easily tolerated by patients. However, the perception of pain associated with prostate biopsies varies widely among patients. Significant number of patients report severe pain during a prostate biopsy. This uncomfortable experience causes patients to refuse any additional biopsy procedures. The prediction of the level of pain to expect and the appropriate anesthesia planned for the procedure are important factors for patient experience. Several studies have investigated the methods of analgesia for reducing the pain of prostate biopsy, while a minor emphasis has focused on other pre-biopsy clinical factors with potential to influence the pain. Only few studies have evaluated factors such as age and the number of biopsy punctures and their impact on pain during the procedure. [4] [5] [6] Therefore, we prospectively evaluated pre-biopsy clinical parameters associated with the level of pain during TRUS-guided prostate biopsies.
Materials and methods
Twelve hospitals (The Korean Urologic Oncology Society, Prostate Cancer Study Group) in Korea participated in this prospective cohort study. Between October 2004 and July 2006, 1781 patients underwent TRUS-guided prostate biopsies and were enrolled in this study. The indications for prostate biopsies included elevation of serum prostate-specific antigens (PSA) (44 ng ml À1 ) and/or abnormal prostate findings on digital rectal examination (DRE). Men who had general anesthesia for biopsies or men who were unable to complete the pain questionnaires were excluded from this study.
All patients received oral antibiotics before the procedure. Depending on the institution or investigator's policies, a cleansing enema was performed. DRE was routinely performed before probe insertion. Oral analgesics (nonsteroidal anti-inflammatory drugs) or periprostatic lidocaine injection was given before biopsy. In cases of periprostatic block, the nerves were bilaterally blocked using 23-g needle and 1% lidocaine 10 ml. The lidocaine 5 ml per side was injected in the groove between the seminal vesicle and the base of the gland. A transrectal ultrasound probe with a diameter of 2.0 cm was inserted and a biopsy needle with a diameter of 18-g and true cut type was equipped into a working channel longitudinal with the rectal probe. Lubricant jelly was used in the process of DRE and probe insertion. The transrectal ultrasonographic imaging was used to determine prostate volume using the ellipsoid formula (volume ¼ (P/6) Â length Â width Â height). Trained urologists or radiologists performed sextant or extended core biopsies (10-12 systematic biopsies) of the prostate. After the procedure, the prostate was compressed with gauge or fingers. Patients continued the oral antibiotics for an additional 3-5 consecutive days after the procedure. Immediately following the biopsy patients were asked to complete a visual analogue scale (VAS) questionnaire using a scale of 0-10 for pain perceived during the procedure.
Distribution of pain score was tested using Kolmogorov-Smirnov test. Age, serum PSA level, prostate volume, enema preparation, methods of analgesia (no control, analgesia use) and numbers of biopsy punctures (sextant, extended) were analyzed using linear regression analysis to determine the factors influencing pain during TRUSguided prostate biopsies. Table 1 shows the clinical characteristics of the participating patients. The median age of patients was 67 years (range: 27-96) and the median PSA level was 7.86 ng ml À1 (range: 0.1-12217.7) ( Table 1) . Small number of patients (18.9%) underwent a sextant biopsy and most of patients (81.1%) underwent the extended biopsy protocols. Oral analgesics were used in 49.5% of the patients and periprostatic lidocaine block was performed in 33.6%. The mean pain score was 2.872.3. Figure 1 shows the distribution of the pain score. No pain (VAS 0) was reported in 450 patients (25.3%) and mild-to-moderate pain (VAS 2-5) in 1078 patients (60.5%), while severe pain (VAS X6) was developed in 253 (14.5%) (Figure 1 ). This distribution was confirmed normally distributed by Kolmogorov-Smirnov test (Figure 2) .
Results
Clinical parameters influencing the pain score associated the prostate biopsy were analyzed independently ( Table 2) . Linear regression analysis showed that patient age, enema preparation, analgesia use and number of biopsy punctures influenced the level of pain during prostate biopsy. However, multivariate analysis revealed that enema preparation, analgesia use and number of biopsy punctures were the factors influencing the level of pain (Table 3) . Patient age was negatively associated with the pain score in the univariate analysis but was not correlated in the multivariate analysis. Enema preparation before biopsy, analgesia use and relatively small number of biopsy punctures reduced the pain-associated prostate biopsy.
Discussion
In previous reports, significant number of patients (22-30%) considered the TRUS-guided prostate biopsy procedure painful and 19% of patients refused repeat biopsies without some type of anesthesia. [7] [8] [9] In our study, a significant number of patients experienced uncomfortable pain throughout the prostate biopsy even with analgesia such as oral analgesics or local lidocaine Clinical factors influencing the development of pain during a prostate biopsy can be divided into patientassociated factors and procedure-associated factors. For the patient-associated factors, age and pre-biopsy anxiety are known to influence the level of pain. [4] [5] [6] Djavan et al.
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found an age-dependent pattern of pain perception that was higher in younger patients (ageo60 years). Rodriguez et al. 6 confirmed a higher discomfort rate in younger patients. Leibovichi et al. 4 reported that pre-biopsy anxiety correlated with the experience of pain during the procedure. In our study, the linear regression analysis showed that patient age influenced the pain score like the previous reports but patient age was not associated with the biopsy pain in the multivariate analysis. In addition, our study showed that patients who received a cleansing enema before the procedure reported a lower pain score compared with patients who received no enema. Cleansing enema improves preparation for the procedure and it reduces the associated pain by securing enough space for movement of the probe in the rectum and preventing unnecessary manipulations during the biopsy procedure.
For the procedure-associated factors, only the number of core biopsies has been reported to influence the level of pain and this finding is controversial. 4, 10, 11 Leibovichi et al.,
4 in a study of 90 patients, reported that the number of biopsy punctures correlated with pain experienced during the procedure, while other studies reported no correlations between them. 10, 11 Our results also showed that the number of biopsy punctures influenced the level of pain during the prostate biopsy and confirmed this with the multivariate analysis.
We could also identify that pain could be reduced from moderate to minimal or mild by providing oral analgesics or periprostatic lidocaine injection. However, there were still patients who experienced stress due to uncontrolled pain during the procedure even with oral analgesics or local lidocaine injection. Irani et al. 9 reported that 16% of patients with no anesthesia had a VAS score equal to or greater than 5. In this study, 14.2% of patients who received periprostatic injection before the procedure reported unpredicted severe pain (VAS X6) during the procedure. These results suggest that some patients should be counseled regarding a risk for greater pain during the procedure, although TRUSguided prostate biopsies are generally well tolerated. The patients with greater than average fear should be considered for general anesthesia before biopsy. Factors influencing pain during TRUS-guided prostate biopsy KS Han et al
Conclusions
Our study confirmed enema preparation before the procedure and the number of biopsy punctures were associated with the pain during TRUS-guided prostate biopsy. A cleansing enema should be routinely performed before the prostate biopsy and patients who will undergo an extended prostate biopsy should be counseled regarding a risk for pain during the procedure.
